Investment
Features
FeesSafety
Academy
More
Pluang+

Roth Capital raises Chord Energy price target to $165 after strong Q3 results and strategic moves.

Analyst Insights
19 Oct 2026
Tony Dante
View Source
Bullish
Roth Capital raises Chord Energy price target to $165 after strong Q3 results and strategic moves.

Roth Capital increased its price target for Chord Energy to $165 from $145 following strong Q3 2026 operational performance, including production exceeding forecasts and capital spending within budget. The company also executed $205 million in share buybacks and sold Marcellus assets for $550 million, boosting shareholder value and liquidity. CEO Michael Lou, who took over in October, highlighted improved well performance and higher adjusted free cash flow. The new target is about 6.9% above the current share price, reflecting confidence in Chord Energy's growth amid mixed analyst ratings.

Chord Energy's price target was raised by Roth Capital to $165. For readers following the Energy sector, here is Pluang's market snapshot as of Oct 20, 2026 01:32 WIB: Out of 79 priced Energy-sector US stocks, 19 rose and 60 fell. Notable movers include Solaris Energy Infrastructure Inc. Class A at USD 65.06 (+3.70%) with balanced buy/sell activity, Energy Fuels Inc at USD 8.17 (-3.54%), and Solaredge Technologies Inc at USD 30.27 (-3.48%) with strong buy interest and a typical hold time of 34 days on Pluang.

More News

Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...

Market News
Bullish
39 minutes ago
Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...

Market News
Bullish
1 hour ago
Miracles prints over 100,000 personalized children's books, serving 45,000+ families with fast German delivery.

Miracles prints over 100,000 personalized children's books, serving 45,000+ families with fast German delivery.

Miracles, a company specializing in personalized children's books where each child becomes the story's hero, has printed over 100,000 books for more than 45,000 families. The books are printed locally in Germany and delivered within a few days, offer...

Others
Bullish
1 hour ago
Miracles prints over 100,000 personalized children's books in the USA, loved by 45,000+ families.

Miracles prints over 100,000 personalized children's books in the USA, loved by 45,000+ families.

Miracles, a personalized children's book maker, has printed more than 100,000 books, serving over 45,000 families. Each book features a unique 3D character of the child, created from a single photo, making the child the hero of the story. Books for U...

Others
Neutral
1 hour ago
RBC keeps Outperform on MDA Space despite lower price target; CSG buys 9.5% stake ahead of Q3 results.

RBC keeps Outperform on MDA Space despite lower price target; CSG buys 9.5% stake ahead of Q3 results.

RBC Capital maintains an Outperform rating on MDA Space but lowers its price target from C$60 to C$55, signaling confidence in the stock despite a more cautious valuation. MDA Space, a Canadian space tech company, is set to release its Q3 financial r...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App